Bakker; Margaretha Henrica Maria

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bakker; Margaretha Henrica Maria.The latest application filed is for "tricyclic quinoline and quinoxaline derivatives".

Company Profile

5.27.27

Bakker; Margaretha Henrica Maria - Ludwigshafen DE
Bakker; Margaretha Henrica Maria - Seeheim-Jugenheim DE
Bakker; Margaretha Henrica Maria - Alsbach-Haehnlein DE
Bakker; Margaretha Henrica Maria - 2340 Beerse BE
Bakker, Margaretha Henrica Maria - Alsbach-Haehlein DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tricyclic Quinoline And Quinoxaline Derivatives App 20200283439 - Koolman; Hannes ; et al.	2020-09-10
Proline Amide Compounds And Their Azetidine Analogues Carrying A Specifically Substituted Benzyl Radical App 20200039930 - Backfisch; Gisela ; et al.	2020-02-06
Hexahydropyrazinobenz- Or -pyrido-oxazepines Carrying An Oxygen-containing Substituent And Use Thereof In The Treatment Of 5-ht2 App 20200002354 - Backfisch; Gisela ; et al.	2020-01-02
Tricyclic Quinoline And Quinoxaline Derivatives App 20190071443 - Koolman; Hannes ; et al.	2019-03-07
Tricyclic Quinoline And Quinoxaline Derivatives App 20190048007 - Koolman; Hannes ; et al.	2019-02-14
Hexahydropyrazinobenz- Or -pyrido-oxazepines Carrying An Oxygen-containing Substituent And Use Thereof In The Treatment Of 5-ht2c-dependent Disorders App 20180339996 - BACKFISCH; Gisela ; et al.	2018-11-29
Tricyclic quinoline and quinoxaline derivatives Grant 10,118,926 - Koolman , et al. November 6, 2	2018-11-06
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors Grant 10,100,048 - Turner , et al. October 16, 2	2018-10-16
Tricyclic quinoline and quinoxaline derivatives Grant 9,994,568 - Koolman , et al. June 12, 2	2018-06-12
Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors Grant 9,856,234 - Turner , et al. January 2, 2	2018-01-02
Hexahydrodiazepinoquinolines Carrying A Cyclic Radical App 20170158693 - BACKFISCH; Gisela ; et al.	2017-06-08
Hexahydrodiazepinoquinolines Carrying A Substituted Alkyl Radical App 20170112851 - BACKFISCH; Gisela ; et al.	2017-04-27
Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators Grant 9,573,950 - Backfisch , et al. February 21, 2	2017-02-21
Hexahydrodiazepinoquinolines carrying a substituted alkyl radical Grant 9,540,376 - Backfisch , et al. January 10, 2	2017-01-10
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors Grant 9,540,370 - Turner , et al. January 10, 2	2017-01-10
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20160194320 - Turner; Sean Colm ; et al.	2016-07-07
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors Grant 9,266,855 - Turner , et al. February 23, 2	2016-02-23
Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor) Grant 9,242,933 - Geneste , et al. January 26, 2	2016-01-26
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20160016932 - Turner; Sean Colm ; et al.	2016-01-21
Tricyclic Quinoline And Quinoxaline Derivatives App 20160016954 - Koolman; Hannes ; et al.	2016-01-21
Tricyclic quinoline and quinoxaline derivatives Grant 9,169,253 - Koolman , et al. October 27, 2	2015-10-27
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20150274724 - Turner; Sean Colm ; et al.	2015-10-01
Hexahydrodiazepinoquinolines Carrying A Substituted Alkyl Radical App 20150259346 - BACKFISCH; Gisela ; et al.	2015-09-17
Hexahydrodiazepinoquinolines Carrying A Cyclic Radical App 20150259343 - BACKFISCH; Gisela ; et al.	2015-09-17
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors Grant 9,090,592 - Turner , et al. July 28, 2	2015-07-28
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase 3 Inhibitors App 20140148458 - Turner; Sean Colm ; et al.	2014-05-29
Small molecule potentiators of metabotropic glutamate receptors I Grant 8,664,214 - Braje , et al. March 4, 2	2014-03-04
Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors Grant 8,642,598 - Turner , et al. February 4, 2	2014-02-04
1-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3) Grant 8,455,648 - Turner , et al. June 4, 2	2013-06-04
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors Grant 8,318,793 - Turner , et al. November 27, 2	2012-11-27
Small molecule potentiators of metabotropic glutamate receptors Grant 8,314,120 - Braje , et al. November 20, 2	2012-11-20
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20120172376 - Turner; Sean Colm ; et al.	2012-07-05
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20120077840 - Turner; Sean Colm ; et al.	2012-03-29
Novel Small Molecule Potentiators Of Metabotropic Glutamate Receptors I App 20110245232 - Braje; Wilfried ; et al.	2011-10-06
Novel Small Molecule Potentiators Of Metabotropic Glutamate Receptors App 20110245247 - Braje; Wilfried ; et al.	2011-10-06
1-(7-(hexahydropyrrolo [3, 4-c] Pyrrol-2 (1h)-yl) Quinolin-4-yl) -3- (pyrazin-2-yl) Urea Derivatives And Related Compounds As Glycogen Synthase Kinase 3 (gsk-3) App 20110105528 - Turner; Sean Colm ; et al.	2011-05-05
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase-3 Inhibitors App 20110003810 - Turner; Sean Colm ; et al.	2011-01-06
Heterocyclic Compounds And Their Use As Glycogen Synthase Kinase 3 Inhibitors App 20100324042 - Turner; Sean Colm ; et al.	2010-12-23
Fused heterocyclic isoxazoline derivatives and their use as anti-depressants Grant 7,501,418 - Andres-Gil , et al. March 10, 2	2009-03-10
C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants Grant 7,465,741 - Andres-Gil , et al. December 16, 2	2008-12-16
C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants Grant 7,462,717 - Andres-Gil , et al. December 9, 2	2008-12-09
HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 receptor) App 20080300260 - GENESTE; Herve ; et al.	2008-12-04
Substituted amino isoxazoline derivatives and their use as anti-depressants Grant 7,265,103 - Andres-Gil , et al. September 4, 2	2007-09-04
Isoxazoline derivatives as anti-depressants Grant 7,169,786 - Andres-Gil , et al. January 30, 2	2007-01-30
C6-and c9-substituted isoxazoline derivatives and their use as anti-depressants App 20060122167 - Andres-Gil; Jose Ignacio ; et al.	2006-06-08
C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants App 20050256119 - Andres-Gil, Jose Ignacio ; et al.	2005-11-17
Substituted amino isoxazoline derivatives and their use as anti-depressants App 20050222125 - Andres-Gil, Jose Ignacio ; et al.	2005-10-06
Isoxazoline derivatives as anti-depressants App 20040122037 - Andres-Gil, Jose Ignacio ; et al.	2004-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.